isoxazoles has been researched along with Cancer of Pituitary in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Dou, G; Hu, F; Jiang, S; Li, J; Li, Y; Sheng, C; Wang, X; Wu, B; Zhang, Y; Zhao, G; Zhong, S | 1 |
| Mike, A; Pesti, K; Szabo, AK; Vizi, ES | 2 |
3 other study(ies) available for isoxazoles and Cancer of Pituitary
| Article | Year |
|---|---|
T5224, RSPO2 and AZD5363 are novel drugs against functional pituitary adenoma.
Topics: Antineoplastic Agents; Benzophenones; Cell Line; Gene Expression Regulation; Gene Regulatory Networks; Humans; Isoxazoles; Oligonucleotide Array Sequence Analysis; Pituitary Gland; Pituitary Neoplasms; Pyrimidines; Pyrroles | 2019 |
Mode of action of the positive modulator PNU-120596 on α7 nicotinic acetylcholine receptors.
Topics: Acetylcholine; Allosteric Regulation; alpha7 Nicotinic Acetylcholine Receptor; Animals; Biophysics; Cell Line, Tumor; Choline; Computer Simulation; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Isoxazoles; Membrane Potentials; Models, Biological; Nicotinic Agonists; Patch-Clamp Techniques; Phenylurea Compounds; Pituitary Neoplasms; Rats; Transfection | 2014 |
Kinetic properties and open probability of α7 nicotinic acetylcholine receptors.
Topics: Acetylcholine; alpha7 Nicotinic Acetylcholine Receptor; Animals; Biophysical Phenomena; Cell Line, Tumor; Choline; Computer Simulation; Dose-Response Relationship, Drug; Electric Stimulation; Isoxazoles; Membrane Potentials; Models, Biological; Nicotinic Agonists; Patch-Clamp Techniques; Phenylurea Compounds; Pituitary Neoplasms; Rats; Transfection | 2014 |